UBE2I and neoplasm: Additionally, SAE1 companied by E2 UBC9 and E3 ligase PIAS4 mediates AKT SUMOylation majorly at K276, regulating AKT activation and promoting tumor progression, which can be reversed by SENP1 [127, 128, 129].